Target intelligence / Profile preview

Guanylate-binding protein 4 (GBP4)

Target
GBP4
Molecular classification
Enzyme, GTPase (large GTPase), Dynamin superfamily, Interferon-inducible protein
01

Overview

Guanylate-binding protein 4 (GBP4) is a member of the guanylate-binding proteins, a subset of the dynamin superfamily of large GTPases that are induced by interferons and play critical roles in innate immune defense, particularly via cell-autonomous immunity against a range of intracellular pathogens including bacteria, viruses, and protozoa. Like other GBPs, GBP4 binds and hydrolyzes GTP, and is involved in processes such as autophagy, inflammasome activation, and potentially membrane remodeling and restriction of pathogen replication. While much research has focused on other family members (like GBP1, GBP2, and GBP5), GBP4 shares significant sequence and structural similarity, and is presumed to act by analogous mechanisms. As of now, GBP4 is not directly targeted by approved drugs but its expression is a marker of interferon pathway activation, and modulation of its activity could impact immune responses to infection and inflammation.

Other names
Guanylate-binding protein 4GBP4GBP-4Mpa2GTP-binding protein 4Guanine nucleotide-binding protein 4
02

Mechanism of action

Not applicable; drugs targeting GBP4 specifically are not reported as of current knowledge

03

Biological functions

Innate immune responseCell-autonomous immunity against intracellular pathogensGTP binding and hydrolysisAutophagy promotionParticipation in inflammasome assembly
04

Disease associations

InfectionInflammationPotential roles in cancer (as inferred from GBP family context)
05

Safety considerations

No GBP4-specific safety concerns described; generally, modulation of innate immunity can carry risks such as immune dysregulation
06

Interacting drugs

No approved drugs are known to directly target GBP4; the broader GBP family is not a current direct drug target
07

Biomarkers

Induction by interferon (GBP4 and other GBPs are interferon-inducible and may serve as markers for interferon activity or inflammation)

Beyond the preview

Go deeper on Guanylate-binding protein 4 (GBP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate-binding protein 4 (GBP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call